Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Virtual Booth

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

2DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Asn90, Asn-90, Schembl17541655, Bdbm508588, Glxc-25525, Ex-a7300

Molecular Formula

C₁₇H₂₁N₅O₃S

Molecular Weight

375.4 g/mol

InChI Key

PLUUAFJXXNCXSD-NSHDSACASA-N

FDA UNII

E9QIS63WUM

1 2D Structure

ASN90

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

N-[5-[4-[(1S)-1-(1,3-benzodioxol-5-yl)ethyl]piperazin-1-yl]-1,3,4-thiadiazol-2-yl]acetamide

2.1.2 InChI

InChI=1S/C17H21N5O3S/c1-11(13-3-4-14-15(9-13)25-10-24-14)21-5-7-22(8-6-21)17-20-19-16(26-17)18-12(2)23/h3-4,9,11H,5-8,10H2,1-2H3,(H,18,19,23)/t11-/m0/s1

2.1.3 InChI Key

PLUUAFJXXNCXSD-NSHDSACASA-N

2.1.4 Canonical SMILES

CC(C1=CC2=C(C=C1)OCO2)N3CCN(CC3)C4=NN=C(S4)NC(=O)C

2.1.5 Isomeric SMILES

C[C@@H](C1=CC2=C(C=C1)OCO2)N3CCN(CC3)C4=NN=C(S4)NC(=O)C

2.2 Other Identifiers

2.2.1 UNII

E9QIS63WUM

2.3 Synonyms

2.3.1 Depositor-Supplied Synonyms

1. Asn90

2. Asn-90

3. Schembl17541655

4. Bdbm508588

5. Glxc-25525

6. Ex-a7300

7. Us11046712, No 68

8. Us11046712, No 69

9. (r)n-(5-(4-(1-(benzordin,31dioxol-5-yl)ethyl)piperazin-1-yl)-1,3,4-thiadiazol-2-yl)acetamide And (s)n-(5-(4-(1-(benzofdlh,31dioxol-5-yl)ethyl)piperazin-1-yl)-1,3,4-thiadiazol-2-yl)acetamide

10. (s)-n-(5-(4-(1-(benzo(d)(1,3)dioxol-5-yl)ethyl)piperazin-1-yl)-1,3,4-thia-diazol-2-yl)acetamide

11. 1884154-02-2

12. Acetamide, N-(5-(4-((1s)-1-(1,3-benzodioxol-5-yl)ethyl)-1-piperazinyl)-1,3,4-thiadiazol-2-yl)-

13. N-[5-[4-[(1s)-1-(1,3-benzodioxol-5-yl)ethyl]piperazin-1-yl]-1,3,4-thiadiazol-2-yl]acetamide

2.4 Create Date

2016-04-09

3 Chemical and Physical Properties

Molecular Formula	C₁₇H₂₁N₅O₃S
Molecular Weight	375.4 g/mol
XLogP3	1.9
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	8
Rotatable Bond Count	4
Exact Mass	g/mol
Monoisotopic Mass	g/mol
Topological Polar Surface Area	108
Heavy Atom Count	26
Formal Charge	0
Complexity	505
Isotope Atom Count	0
Defined Atom Stereocenter Count	1
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1